Skip to content
10-K

Annual Report

NEON THERAPEUTICS, INC.

0001694187-20-000020

← back to feed
Filed
Mar 2, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2019 · Feb 26, 2020 28.86M sh
Capex FY 2019 · Dec 31, 2019 $1.08M
Capex FY 2019 · Dec 31, 2018 $3.22M
Operating Cash Flow FY 2019 · Dec 31, 2019 −$73.41M
Operating Cash Flow FY 2019 · Dec 31, 2018 −$63.43M
Cash And Equivalents FY 2019 · Dec 31, 2019 $29.4M
Cash And Equivalents FY 2019 · Dec 31, 2018 $52.7M
Stockholders Equity FY 2019 · Dec 31, 2019 $29.42M
Stockholders Equity FY 2019 · Dec 31, 2018 $101.25M
Stockholders Equity FY 2019 · Dec 31, 2017 −$93.57M
Current Liabilities FY 2019 · Dec 31, 2019 $10.41M
Current Liabilities FY 2019 · Dec 31, 2018 $12.69M
Total Liabilities FY 2019 · Dec 31, 2019 $16.96M
Total Liabilities FY 2019 · Dec 31, 2018 $12.84M
Current Assets FY 2019 · Dec 31, 2019 $31.24M
Current Assets FY 2019 · Dec 31, 2018 $105.43M
Total Assets FY 2019 · Dec 31, 2019 $46.37M
Total Assets FY 2019 · Dec 31, 2018 $114.09M
Sga Expense FY 2019 · Dec 31, 2019 $21.42M
Sga Expense FY 2019 · Dec 31, 2018 $18.28M
Rd Expense FY 2019 · Dec 31, 2019 $59.72M
Rd Expense FY 2019 · Dec 31, 2018 $60.43M
Net Income FY 2019 · Dec 31, 2019 −$79.78M
Net Income FY 2019 · Dec 31, 2018 −$23.12M
Net Income FY 2019 · Dec 31, 2018 −$76.93M
Net Income FY 2019 · Sep 30, 2018 −$18.39M
Net Income FY 2019 · Jun 30, 2018 −$18.9M
Net Income FY 2019 · Mar 31, 2018 −$16.52M
Operating Income FY 2019 · Dec 31, 2019 −$81.14M
Operating Income FY 2019 · Dec 31, 2018 −$78.7M